S100P antibody-mediated therapy as a new promising strategy for the treatment of pancreatic cancerJosé Luís Hernández(Leitat Technological Center)OncogenesisMarch 17, 201410.1038/oncsis.2014.7Cited by 61SaveCiteExport RISWatch citationsRelated PapersTherapeutic Targeting of Tumor Growth and Angiogenesis with a Novel Anti-S100A4 Monoclonal Antibody|PLoS ONE|2013|107